Carcinoid Cancer Foundation Thanks Symposium Sponsors

There’s still time to register for the Carcinoid Cancer Foundation’s 14th annual  symposium for patients, family, friends, and healthcare professionals, which will be held on Sunday, May 1st at Mount Sinai Medical Center in New York City.  The Foundation would like to thank the sponsors whose generosity has helped make possible this important event for the carcinoid and neuroendocrine tumor community:

 Presenting Sponsor

Novartis Oncology

 Novartis Oncology Sponsors Carcinoid Cancer Foundation Symposium


Dima Family

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Sponsors Carcinoid Cancer Foundation Symposium

Patricia and George Mentonis

Neuroendocrine Tumor Management:  The Era of Personalized Medicine is the theme of the symposium.  Guests will have the opportunity to hear from three of the leading carcinoid/NET cancer specialists in the United States and internationally.  Dr. Richard R.P. Warner, Director of the Center for Carcinoid and Neuroendocrine Tumors at Mt. Sinai and Medical Director of the Carcinoid Cancer Foundation, will give introductory remarks.  The guest speakers will be Dr. Edward M. Wolin, Co-Director of the Carcinoid and Neuroendocrine Tumor Program at Cedars-Sinai Medical Center in Los Angeles, California, and Dr. Eugene A. Woltering, James D. Rives Professor of Surgery and Neurosciences at Louisiana State University Health Sciences Center in New Orleans, Louisiana.

Carcinoid and NETs in 2011: Now, New, Next will be the focus of Dr. Wolin’s presentation.  What are the current treatments for carcinoid/NET patients and what is expected in the coming years?  What is the role of personalized and biologically targeted chemotherapy in NET treatment?  How do somatostain analogs work and why are they important for NET patients?

Dr. Edward Wolin

Dr. Edward Wolin

Dr. Woltering’s presentation, From the Bedside to the Laboratory and Back Again, will examine where NETs come from, how they are diagnosed, tests used for diagnosis and monitoring, therapies, and more.

Dr. Eugene Woltering

Dr. Eugene Woltering

A patient panel will be presented and moderated by Gilles Frydman, founder of ACOR (Association of Cancer Online Resources), an online cancer-related community reaching over 1.5 million people weekly across the globe. Mr. Frydman is also a member of the Founding Circle, Society of Participatory Medicine.

Gilles Frydman

ACOR founder Gilles Frydman

To register, CLICK HERE.  For further information, call the Carcinoid Cancer Foundation at 888-722-3132We look forward to seeing you on May 1!

This entry was posted in carcinoid, carcinoid and neuroendocrine tumor conferences, carcinoid and neuroendocrine tumor treatments, carcinoid cancer, Carcinoid Cancer Foundation, Carcinoid Cancer Foundation symposium, carcinoid doctors, NET (neuroendocrine tumor) cancer, rare cancers, rare diseases and tagged , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s